Viewing nowCombinationTrachideu Duo Extended-Release Tablet 5/1000 mg (Linagliptin, Metformin Hydrochloride)
Linagliptin Micronized 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202400024 · Approved 2024.01.04 · Insurance code 671707370
Improves blood glucose control in patients with type 2 diabetes
This medication is prescribed to assist patients with type 2 diabetes who are taking linagliptin and metformin together in controlling their blood sugar levels. It is more effective when combined with diet and exercise, helping to improve blood sugar levels. This supports patients in managing their diabetes more effectively. It is important to take it safely while maintaining healthy lifestyle habits.
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: linagliptin 5mg and metformin hydrochloride extended-release 2000 mg. Take this medicine once daily with a meal, preferably with the evening meal. To reduce gastrointestinal adverse reactions associated with metformin use, the metformin hydrochloride dose should be increased gradually. Take one 5/1000 mg extended-release tablet once daily. Patients taking this medicine as 2.5/1000 mg extended-release tablets should take 2 tablets together once daily. 1. Patients not currently treated with metformin: The initial total daily dose of this medicine is linagliptin 5 mg and metformin hydrochloride 1000mg; the dose of metformin hydrochloride may be gradually increased up to the maximum recommended daily dose of 2000 mg. 2. Patients receiving treatment with metformin - For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine is a total daily dose of linagliptin 5 mg and the patient's current dose of metformin hydrochloride. - For patients who cannot achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea, or metformin and insulin, an initial dose of this medicine equivalent to a total daily dose of linagliptin 5mg and the patient's current dose of metformin hydrochloride should be considered. When this medicine is administered in combination with insulin or a sulfonylurea, a reduction in the dose of insulin or the sulfonylurea may be needed to reduce the risk of hypoglycemia (see Precautions for Use, 2. Patients Requiring Caution). - When switching from immediate-release metformin to the extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately if necessary. - When switching from combination therapy with linagliptin and extended-release metformin to this medicine, the dose of this medicine should be equivalent to the patient's current doses of linagliptin and extended-release metformin hydrochloride. No dose adjustment is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60mL/min or estimated glomerular filtration rate (eGFR) ≧ 60mL/min/1.73 m2]. In patients with moderate renal impairment (CKD stage 3A), defined as creatinine clearance (CrCl) ≥45mL/min and <60mL/min or estimated glomerular filtration rate (eGFR) ≥45mL/min/1.73m2 and <60mL/min/1.73m2, this medicine may be used with adjustment of the metformin hydrochloride dose as follows, provided it is well tolerated and there are no other conditions that may increase the risk of lactic acidosis. Because the starting dose of metformin hydrochloride is 500mg or 750mg once daily, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to <45mL/min or estimated glomerular filtration rate (eGFR) decreases to <45mL/min/1.73m2, this medicine must be discontinued immediately.
This medication contains two active ingredients, linagliptin and metformin hydrochloride. Firstly, metformin hydrochloride can rarely cause a serious condition known as lactic acidosis, which can be dangerous due to the excessive accumulation of lactic acid in the body. Therefore, patients with severely impaired kidney function or those with dehydration, severe infections, acute heart problems, etc., should not use this medication. Additionally, those with an allergy to any component of this medication or with type 1 diabetes, diabetic ketoacidosis, or severe liver dysfunction should avoid using it. When using this medication, it is essential to be aware of hypoglycemic symptoms, particularly because the risk of hypoglycemia may increase when taken with sulfonylureas or insulin, requiring dosage adjustments. To reduce the risk of lactic acidosis, it is important to consult your physician immediately if dehydrating symptoms or declining kidney function are suspected and, if necessary, temporarily discontinue the medication. This medication is excreted through the kidneys, so periodic monitoring of kidney function is required, with extra caution needed for elderly patients with impaired kidney function. Patients with poor cardiac function or those with conditions such as acute myocardial infarction or shock should also use this medication with caution. If you receive iodinated contrast agents used during radiological examinations, you should temporarily discontinue this medication for a specified period before and after the examination, and confirm kidney function. Patients scheduled for surgery should also stop taking this medication for a specified period before and after surgery. Acute pancreatitis or skin blistering conditions may occur while taking this medication; therefore, if you experience abdominal pain or skin abnormalities, inform your doctor immediately. Long-term use may lower vitamin B12 levels, so it is advisable to check vitamin B12 levels if you experience anemia or neurological symptoms. This medication should be swallowed whole and not chewed or crushed. It is normal for the shell of the tablet to pass through the stool without being dissolved. There may be interactions with other medications; thus, you should inform your physician or pharmacist of any medications you are currently taking. Avoid using this medication if you are pregnant or breastfeeding, as safety for children has not been established. For elderly patients, appropriate dosage adjustments and regular kidney function assessments are necessary due to potential declines in kidney function. In the event of overdose, serious side effects such as lactic acidosis may occur, and immediate medical attention is required. Finally, this medication should be stored out of reach of children, protected from moisture, and not transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's efficacy and safety.
White oval extended-release film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin Micronized 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.